DacryocystitisNCT00349297
The Microbiological Spectrum in Acute Dacryocystitis
An observational study of Dacryocystitis, run by Singapore National Eye Centre at 1 site in Singapore.
Trial summary
Acute dacryocystitis in adults can be a very painful disease and may not respond well to medical therapy. The purpose of this prospective non-randomised study is to determine the microorganisms causing acute dacryocystitis and the antibiotic sensitivities of these organisms. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Dacryocystitis
- How many people
- Not given
- Where
- 1 siteSingapore
- Study dates
- Nov 2003to May 2008
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Acute dacryocystitis patients
Who may be able to join
- Painful localised fluctuant induration just inferior to the medial canthal tendon of less than 2 weeks duration.
Who cannot join
- Non-fluctuant lacrimal sac swelling
- Uncooperative patient
- Unwilling Patient
Trial locations and contacts
1 site in 1 country.
About this study
Acute dacryocystitis in adults can be a very painful disease and may not respond well to medical therapy.
The purpose of this prospective non-randomised study is to determine the microorganisms causing acute dacryocystitis and the antibiotic sensitivities of these organisms.
The study also aims to correlate the microbiological findings to the severity of clinical manifestations and evaluate the effectiveness of our current practice of aspiration and empiric systemic antibiotic therapy in treating patients with acute dacryocystitis and hence review whether there is a need to alter current management strategy.
- Conditions
- Dacryocystitis
- Medical subject headings
- Dacryocystitis
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted6 Jul 2006 (estimated)
- Study startNov 2003
- Primary completionMay 2008
- Study completionMay 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DacryocystitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Time perspective
- Prospective
Sponsor and investigators
- Lead sponsor
- Singapore National Eye Centre
- Sponsor type
- Other government
- Investigators
- Anshu Arundhati, MRCSED, MMED, Principal investigator, Singapore National Eye Centre
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00349297
- Sponsor's protocol ID
- R325/18/2003
- Status last verified
- May 2010
- First submitted
- 5 Jul 2006
- Last updated
- 12 May 2010
- Results posted
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 May 2010. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Microbiological Spectrum in Acute Dacryocystitis
- ClinicalTrials.gov ID
- NCT00349297
- Acronym / sponsor ID
- R325/18/2003
- Conditions
- Dacryocystitis
- Study type
- Observational
- Recruitment status
- Completed
- Lead sponsor
- Singapore National Eye CentreOther government
- Study start
- Nov 2003
- Primary completion
- May 2008 (actual)
- Study completion
- May 2008 (actual)
- First posted
- 6 Jul 2006 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Acute dacryocystitis in adults can be a very painful disease and may not respond well to medical therapy.
The purpose of this prospective non-randomised study is to determine the microorganisms causing acute dacryocystitis and the antibiotic sensitivities of these organisms.
The study also aims to correlate the microbiological findings to the severity of clinical manifestations and evaluate the effectiveness of our current practice of aspiration and empiric systemic antibiotic therapy in treating patients with acute dacryocystitis and hence review whether there is a need to alter current management strategy.
Study design
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Acute dacryocystitis patients
Key inclusion criteria (1 listed)
- Painful localised fluctuant induration just inferior to the medial canthal tendon of less than 2 weeks duration.
Key exclusion criteria (3 listed)
- Non-fluctuant lacrimal sac swelling
- Uncooperative patient
- Unwilling Patient
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Not reported in the source record.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 May 2010.
Related trials for Dacryocystitis
Active, not recruitingPhase 4
Efficacy and Safety of Piclosept in the Complex Treatment of Neonatal Dacryocystitis
Neonatal Dacryocystitis, Congenital Nasolacrimal Duct Obstruction
RecruitingPhase 2
Absorbable Drug-Eluting Lacrimal Sac Stent for Recurrent Chronic Dacryocystitis
Chronic Dacryocystitis
Not yet recruitingPhase 4
Hyaluronic Acid vs Mitomycin-C in External Dacryocystorhinostomy
Dacryocystitis
RecruitingObservational study
"My Eyes, My Light": Amar Chokh, Amar Alo
Glaucoma, Diabetic Retinopathy (DR)
RecruitingPhase 4
Does Topical Ophthalmic Proparacaine 0.5% Prior to Probing and Irrigation Decrease Pain?
Epiphora, Dacryostenosis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Anshu Arundhati, MRCSED, MMED principal investigator
Singapore National Eye Centre
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dacryocystitis, run by Singapore National Eye Centre at 1 site in Singapore.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 May 2010. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Singapore. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2010.